ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Novo Nordisk plans to introduce drug for sickle cell disease in 3-5 years
The company announced the plan to hire about 1,300 new employees by the end of 2026, as per the statement at a media briefing
Announcement as on 06 August 2024

For Alzheimer’s patients, this Novo Nordisk GLP-1 drug slows cognitive decline

Announcement as on 30 July 2024

Can Zaynich do for Wockhardt what Ozempic did for Novo Nordisk?
Wockhardt's Zaynich antibiotic surged stock by 75%. CEO Habil Khorakiwala cited its uniqueness; phase three trials end this fiscal year. Compared to Novo Nordisk's Ozempic, Zaynich’s billion potential counters global antibiotic resistance.
Announcement as on 06 July 2024

Why Novo Nordisk Topped the Market Today
Hardly for the first time in recent weeks and months, Novo Nordisk (NYSE: NVO) had a good trading session on the stock market Monday. The company's shares enjoyed a more than 2% boost on the day, comparing favorably to the 0.9% rise of the S&P 500 inde
Announcement as on 22 April 2024

Novo Nordisk to buy Cardior Pharma for up to billion
Novo Nordisk A/S bought Cardior Pharmaceuticals for billion to enhance cardiovascular treatments. Cardior's microRNA-targeting therapies aim to improve heart function, aligning with Novo's focus on diabetes and obesity history.
Announcement as on 26 March 2024

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 48.69
  • 12Day Average: 46.84
  • 20Day Average: 45.33
  • 50Day Average: 44.61
  • 100Day Average: 42.3
  • 150Day Average: 45.95
  • 200Day Average: 47.8

NVO Indicators & signals

Indicator MACD (12,26,9)

47.31, 45.85, 0.95
Indicator MACD is in positive zone

Indicator ADX (14)

43.66, 32.08, 12.58
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 57
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
02 Thu Jul 2026 50.42 48.61 to 50.90 3.36% 0.96 times
01 Wed Jul 2026 48.78 47.80 to 49.55 1.79% 0.85 times
30 Tue Jun 2026 47.92 47.87 to 48.80 -0.85% 0.59 times
29 Mon Jun 2026 48.33 47.44 to 48.48 0.67% 0.64 times
26 Fri Jun 2026 48.01 46.70 to 48.50 0.8% 1.49 times
25 Thu Jun 2026 47.63 47.13 to 48.24 0.46% 0.8 times
24 Wed Jun 2026 47.41 46.51 to 47.65 -0.02% 1.01 times
23 Tue Jun 2026 47.42 46.44 to 47.43 3.31% 1.75 times
22 Mon Jun 2026 45.90 43.87 to 46.45 6.27% 1.28 times
18 Thu Jun 2026 43.19 42.52 to 44.17 -0.76% 0.6 times
17 Wed Jun 2026 43.52 43.46 to 45.00 -0.11% 0.98 times
16 Tue Jun 2026 43.57 43.36 to 44.43 -0.8% 0.51 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

 

Back to top